In conclusion, our results and previous mechanistic studies could advance the understanding of the level of glucose metabolism and the expression of glucose metabolism-regulating enzymes in CRPC, which provide a rationale for further clinical investigation of tumor treatment focused on controlling PFKFB4 expression. This evidence concerns the gene PFKFB4 and neoplasm.